Our speakers reviewed the racial, economic and social determinants of health (SDoH) impacting healthcare among the most vulnerable in our society.
Our webinar speakers explored the state of COVID-19 and asthma care as of June 2020 and discussed the potential future for schools and businesses.
Dr. John Oppenheimer reviewed biologic medications that are changing asthma and allergy care providing more personalized options for treatment.
The presenter discusses the prevalence of allergic reactions to cannabis (marijuana); information on diagnosis & management; benefits & harms.
This webinar covered Section 504 plans for students at risk for anaphylaxis, legal rights for students, IHPs & emergency plans.
The presenters discussed COVID-19 considerations in the care of asthma & other acute & chronic lung conditions as we slowly reopen our economy and society.